Previous 10 | Next 10 |
PORTLAND, Maine, July 07, 2021 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the he...
The following slide deck was published by ImmuCell Corporation in conjunction with their 2021 Q1 earnings call. For further details see: ImmuCell Corporation 2021 Q1 - Results - Earnings Call Presentation
ImmuCell Corporation (ICCC) Q1 2021 Earnings Conference Call May 14, 2021 09:00 ET Company Participants Joe Diaz - Investor Relations Michael Brigham - President and Chief Executive Officer Conference Call Participants Sam Rebotsky - SER Asset Management Jenifer Taylor - MAC Funds Presentatio...
PORTLAND, Maine, May 13, 2021 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the hea...
PORTLAND, Maine, May 06, 2021 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the hea...
PORTLAND, Maine, April 14, 2021 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the h...
ImmuCell (ICCC) reported prelim sales for first quarter ended Mar. 31, 2021."We expect to report a 16%, or $791K, decrease in total product sales to ~$4.1M during the quarter ended Mar. 31, 2021 versus the same period of the prior year, during which our sales benefitted from a higher level of...
PORTLAND, Maine, April 07, 2021 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the h...
ImmuCell Corporation (ICCC) Q4 2020 Earnings Conference Call February 23, 2021 09:00 A.M. ET Company Participants Joe Diaz - Lytham Partners Michael F. Brigham - President and CEO Conference Call Participants Sam Rebotsky - SER Asset Management George Melas-Kyriazi - MKH Management Unidentifi...
PORTLAND, Maine , Feb. 22, 2021 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve ...
News, Short Squeeze, Breakout and More Instantly...
2024-04-17 08:58:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
PORTLAND, Maine, April 09, 2024 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health ...
2024-04-07 15:10:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...